In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
State agents say a Summerville shop operator kept running it after his license was revoked, used a false name, and threatened ...
Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
ContrastConnect has updated its outlook on virtual contrast supervision following the signing of California Assembly Bill 460 ...
Taking these timeframes into account, the earliest (best case scenario) the new sales tax of 10.7% would take effect in ...
ContrastConnect has updated its guide to implementing virtual contrast supervision in imaging centers, aligning with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback